Trial Name |
Description |
Click for further information (external page) |
Date opened |
C34004 |
Phase 2 Study of TAK-659 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
|
|
October 2017
|
JAVELIN DLBCL |
A phase 1/3 trial testing a new drug avelumab.
|
|
October 2017
|
PQR309-005 |
A phase 2 trial testing a targeted drug, PQR309.
|
![]() |
November 2017
|
INCYTE (CITADEL-202) |
A phase 2 trial testing a new drug, INCB050465
|
![]() |
October 2017
|
This list is updated fortnightly. Click here to see all of our open clinical trials.